Market Overview

BMO Capital Upgrades Halozyme Therapeutics, Inc. to Outperform, Raises to $12.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for HALO

DateFirmActionFromTo
Sep 2017BMO CapitalMaintainsMarket Perform
Apr 2017BMO CapitalInitiates Coverage OnMarket Perform
Nov 2016Deutsche BankInitiates Coverage OnBuy

View More Analyst Ratings for HALO
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (HALO)

Loading...